Company Profile

Epigenetix is a platform drug discovery company focused on the field of epigenetics across various projects. With a strong small molecule medicinal chemistry alliance with IntelliSynRD ( www.IntelliSynRD.com ) in Montreal and with several additional collaborative arrangements, the firm's field of specialty organizes around changes in gene activities that are not caused by hereditary changes in the DNA sequence. Proper epigenetic regulation is essential to human health and development. Epigenetic dysregulation is thought to be a critical contributor to many diseases including cancer. The focus of Epigenetix is to address serious unmet medical needs to include cancer and brain disorders by correcting (or compensating) for harmful epigenetic changes that contribute to or cause disease.